Published in Hum Reprod on March 01, 2003
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod (2002) 1.96
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod (2004) 3.56
Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update (2008) 3.31
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod Biomed Online (2011) 2.79
Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet (2005) 2.73
In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med (2006) 2.41
Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod (2006) 2.18
Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil Steril (2002) 2.16
Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril (2005) 2.09
Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod (2002) 1.98
A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril (2011) 1.85
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod (2007) 1.82
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril (2006) 1.81
Live birth after transplantation of frozen-thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil Steril (2012) 1.80
Primary ovarian insufficiency. Lancet (2010) 1.67
Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update (2008) 1.67
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod (2007) 1.66
Follicular growth and estradiol follow-up after subcutaneous xenografting of fresh and cryopreserved human ovarian tissue. Fertil Steril (2007) 1.58
Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online (2006) 1.56
Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online (2011) 1.51
Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer (2007) 1.48
Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod (2004) 1.47
Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod (2002) 1.46
Are ICSI adolescents at risk for increased adiposity? Hum Reprod (2011) 1.45
The endometrium in stimulated cycles for IVF. Hum Reprod Update (2004) 1.44
"Floating denominators"--effect of verification bias on accuracy estimates for preimplantation diagnosis. Fertil Steril (2003) 1.39
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab (2004) 1.37
Continuous exposure to bisphenol A during in vitro follicular development induces meiotic abnormalities. Mutat Res (2007) 1.33
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril (2003) 1.32
Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril (2002) 1.31
Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril (2005) 1.24
Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod (2005) 1.23
Alpha-fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility. Proc Natl Acad Sci U S A (2002) 1.21
Influence of individual sperm morphology on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic sperm injection. Fertil Steril (2003) 1.20
Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab (2003) 1.19
Chondrosarcoma of the breast. Breast J (2005) 1.18
Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects. Hum Reprod Update (2004) 1.17
Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril (2010) 1.15
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. Reprod Biomed Online (2011) 1.15
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril (2004) 1.14
Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod (2004) 1.12
Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab (2003) 1.11
Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertil Steril (2005) 1.10
Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers. BMC Cancer (2008) 1.05
Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod (2003) 1.05
Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod (2009) 1.05
Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod (2004) 1.05
A reproducible two-step culture system for isolated primary mouse ovarian follicles as single functional units. Biol Reprod (2004) 1.04
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril (2007) 1.04
Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay. Clin Chem Lab Med (2005) 1.04
Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. Reprod Biomed Online (2006) 1.04
Multicentre performance evaluation of the E170 module for modular analytics. Clin Chem Lab Med (2004) 1.03
In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. Hum Reprod (2009) 1.03
Ex-vivo oocyte retrieval for fertility preservation. Fertil Steril (2010) 1.02
Alpha-fetoprotein controls female fertility and prenatal development of the gonadotropin-releasing hormone pathway through an antiestrogenic action. Mol Cell Biol (2006) 1.02
Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod (2006) 1.01
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology. Gynecol Endocrinol (2015) 1.01
Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reprod Biomed Online (2003) 1.01
Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol Reprod (2008) 1.00
The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum Reprod (2008) 0.98
Thyroid dysfunction and autoimmunity in infertile women. Thyroid (2002) 0.98
Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online (2004) 0.98
Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod (2007) 0.98
Molecular control of oogenesis. Biochim Biophys Acta (2012) 0.97
Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. Fertil Steril (2012) 0.97
Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril (2012) 0.97
Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril (2011) 0.97
Culture of oocytes and risk of imprinting defects. Hum Reprod Update (2012) 0.97
Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases. Gynecol Endocrinol (2012) 0.96
Different follicle-stimulating hormone exposure regimens during antral follicle growth alter gene expression in the cumulus-oocyte complex in mice. Biol Reprod (2010) 0.96
Preantral follicle culture as a novel in vitro assay in reproductive toxicology testing in mammalian oocytes. Mutagenesis (2004) 0.96
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril (2003) 0.96
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod (2005) 0.96
Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod (2007) 0.96
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online (2011) 0.95
The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments. Hum Reprod (2012) 0.94
Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles. Fertil Steril (2004) 0.94
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril (2007) 0.94
Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments. Fertil Steril (2006) 0.93
Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors. Fertil Steril (2012) 0.93
Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab (2004) 0.93
Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod (2002) 0.92